In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neuspera Medical closes first tranche in $26mm Series B round; later closes second tranche

Executive Summary

Neuspera Medical Inc. (implantable neuromodulation devices) raised a $14mm tranche (according to the Form D) of a $26mm Series B financing, which was led by 6 Dimensions Capital (added a board member), with participation from all Series A round investors, including Action Potential Venture Capital and Windham Venture Partners. New backers Delta Capital and Purple Arch Ventures also contributed to the round.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies